Reporte zur Charge U7296A

Symptomtext

HCP called to report a TE with MMR II, PROQUAD, VARIVAX, GARDASIL 9, ROTATEQ, VAQTA, VAXELIS PFS. VAXELIS PFS and ROTATEQ were administered; This spontaneous safety report, with reference number 02385069 (Interaction # 02385061) was received by the partner on 08-MAY-2023 and forwarded to agency on 09-MAY-2023, from a health professional. Due to the nature of the event, the causality between the event "HCP called to report a TE with MMR II, PROQUAD, VARIVAX, GARDASIL 9, ROTATEQ, VAQTA, VAXELIS PFS. VAXELIS PFS and ROTATEQ were administered" and Vaxelis was not applicable. Further information is expected. Significant Follow-up information was received by the partner on 16-MAY-2023 and forwarded to agency on 17-MAY-2023, from a health care professional. This case is maintained as non-serious. This case continues to be considered non-valid. The causal relationship between VAXELIS and the reported event of "HCP called to report a TE with MMR II, PROQUAD, VARIVAX, GARDASIL 9, ROTATEQ, VAQTA, VAXELIS PFS. VAXELIS PFS and ROTATEQ were administered is not applicable." Further information is expected.